{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T21:56:18Z","timestamp":1757627778960,"version":"3.44.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T00:00:00Z","timestamp":1755734400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T00:00:00Z","timestamp":1755734400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Lafora disease (LD) is an ultra-rare, autosomal recessive neurodegenerative disorder characterized by the accumulation of Lafora bodies in the brain, leading to drug-resistant epilepsy, myoclonus, progressive dementia, and cerebellar dysfunction. This retrospective study describes the clinical course and management challenges of LD in a cohort of patients from the Apulia region of Southern Italy, where the disease prevalence appears to be higher than in other populations.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We retrospectively analyzed clinical, electroencephalographic, and management data from six unrelated families with a confirmed diagnosis of LD, followed at the Neurology Unit of the Scientific Institute Casa Sollievo della Sofferenza Hospital between 2010 and 2024. Demographic information, clinical presentation, treatment history, disease progression, and outcomes were collected.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Our analysis identified three distinct electroclinical stages: an initial Presenting Symptoms Stage with the onset of seizures and subsequent development of myoclonus; a Progressive Neurodegeneration Stage characterized by drug-resistant epilepsy, dementia, and ataxia; and a Terminal Stage marked by severe disability, frequent seizure emergencies, and medical complications. Management in the late stages proved particularly challenging, requiring a multidisciplinary approach to address refractory seizures, status epilepticus, and medical complications such as aspiration pneumonia and respiratory failure. Home-based care, with specialized team support, played a crucial role in minimizing hospitalizations.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Discussion<\/jats:title>\n            <jats:p>Our findings underscore the importance of early diagnosis and a multidisciplinary approach in the management of LD. The late stages of the disease are characterized by significant clinical challenges necessitating close collaboration among neurologists, epileptologists, and other healthcare professionals, supported by effective home-based care. The apparent higher prevalence in Apulia warrants further investigation into potential genetic or environmental factors.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>This study highlights the significant clinical burden of LD and emphasizes the importance of multidisciplinary management, particularly in the advanced stages. Home-based care supported by specialized teams and caregivers is essential for optimizing patient well-being. Further research is needed to identify early biomarkers and develop targeted therapies for this devastating condition.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13023-025-03976-x","type":"journal-article","created":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T09:47:29Z","timestamp":1755769649000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical course and management challenges in Lafora disease: a narrative analysis in an Apulian cohort"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3465-7540","authenticated-orcid":false,"given":"Giuseppe","family":"d\u2019Orsi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Teresa","family":"Di Claudio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonella","family":"Liantonio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Imbrici","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cosimo Damiano","family":"Altomare","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Orazio","family":"Palumbo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pietro","family":"Palumbo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Benvenuto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Gambacorta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graziano","family":"Lolli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"DEFEAT-LD study group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Bisulli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cinzia","family":"Costa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Damante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lidia","family":"Di Vito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Imperatore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Licchetta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raffaele","family":"Lodi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenzo","family":"Muccioli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Mantuano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serena","family":"Mazzone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Michelucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Pasini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Prontera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Tappat\u00e0","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Vignatelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corrado","family":"Zenesini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Carella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,21]]},"reference":[{"issue":"Suppl 2","key":"3976_CR1","first-page":"S38","volume":"18","author":"J Turnbull","year":"2016","unstructured":"Turnbull J, Tiberia E, Striano P, Genton P, Carpenter S, Ackerley CA, Minassian B. Lafora disease. Epileptic Disord. 2016;18(Suppl 2):S38\u201362.","journal-title":"Epileptic Disord"},{"key":"3976_CR2","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1186\/s13023-021-01989-w","volume":"16","author":"F Pondrelli","year":"2021","unstructured":"Pondrelli F, Muccioli L, Licchetta L, Mostacci B, Zenesini C, Tinuper P, Vignatelli L, Bisulli F. Natural history of Lafora disease: a prognostic systematic review and individual participant data meta-analysis. Orphanet J Rare Dis. 2021;16:362. https:\/\/doi.org\/10.1186\/s13023-021-01989-w.","journal-title":"Orphanet J Rare Dis"},{"key":"3976_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.969297","volume":"13","author":"G d\u2019Orsi","year":"2022","unstructured":"d\u2019Orsi G, Di Claudio MT, Palumbo O, Carella M. Electro-clinical features and management of the late stage of Lafora disease. Front Neurol. 2022;13: 969297. https:\/\/doi.org\/10.3389\/fneur.2022.969297.","journal-title":"Front Neurol"},{"key":"3976_CR4","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.seizure.2020.10.022","volume":"83","author":"G d\u2019Orsi","year":"2020","unstructured":"d\u2019Orsi G, Lalla A, Palumbo O, Di Claudio MT, Valenzano A, Sabetta A, Lopopolo A, Di Muro E, Palumbo P, Copetti M, Carella M, Avolio A. The presenting symptoms of Lafora disease: an electroclinical and genetic study in five Apulian (Southern Italy) families. Seizure. 2020;83:145\u201353.","journal-title":"Seizure"},{"key":"3976_CR5","first-page":"107","volume":"1","author":"CA Tassinari","year":"1978","unstructured":"Tassinari CA, Bureau-Paillas M, Dalla Bernardina B, Picornell-Darder I, Mouren MC, Dravet C, Roger J. La Maladie de Lafora. Rev EEG Neurophysiol. 1978;1:107\u201322.","journal-title":"Rev EEG Neurophysiol"},{"issue":"64","key":"3976_CR6","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1212\/01.WNL.0000154519.10805.F7","volume":"22","author":"C G\u00f3mez-Abad","year":"2005","unstructured":"G\u00f3mez-Abad C, G\u00f3mez-Garre P, Guti\u00e9rrez-Delicado E, Saygi. Lafora disease due to EPM2B mutations: a clinical and genetic study. Neurology. 2005;22(64):982\u20136.","journal-title":"Neurology"},{"key":"3976_CR7","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1111\/j.1528-1167.2005.00272.x","volume":"46","author":"B Baykan","year":"2005","unstructured":"Baykan B, Striano P, Gianotti S, Bebek N, Gennaro E, Gurses C, Zara F. Late-onset and slow-progressing Lafora disease in four siblings with EPM2B mutation. Epilepsia. 2005;46:1695\u20137.","journal-title":"Epilepsia"},{"key":"3976_CR8","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.2005.039479","volume":"43","author":"S Singh","year":"2006","unstructured":"Singh S, Sethi I, Francheschetti S, Riggio C, Avanzini G, Yamakawa K, DelgadoEscueta AV, Ganesh S. Novel NHLRC1 mutations and genotype-phenotype correlations in patients with Lafora\u2019s progressive myoclonic epilepsy. J Med Genet. 2006;43: e48.","journal-title":"J Med Genet"},{"key":"3976_CR9","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1002\/humu.20954","volume":"30","author":"S Singh","year":"2009","unstructured":"Singh S, Ganesh S. Lafora progressive myoclonus epilepsy: a meta-analysis of reported mutations in the first decade following the discovery of the EPM2A and NHLRC1 genes. Hum Mutat. 2009;30:715\u201323.","journal-title":"Hum Mutat"},{"key":"3976_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2021.117409","volume":"424","author":"A Riva","year":"2021","unstructured":"Riva A, Orsini A, Scala M, Taramasso V, Canafoglia L, d\u2019Orsi G, Di Claudio MT, Avolio C, et al. Italian cohort of Lafora disease: clinical features, disease evolution, and genotype-phenotype correlations. J Neurol Sci. 2021;424: 117409.","journal-title":"J Neurol Sci"},{"key":"3976_CR11","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1111\/j.1528-1167.2006.00479.x","volume":"47","author":"S Franceschetti","year":"2006","unstructured":"Franceschetti S, Gambardella A, Canafoglia L, Striano P, Lohi H, Gennaro E, Ianzano L, Veggiotti P, Sofia V, Biondi R, Striano S, Gellera C, Annesi G, Madia F, Civitelli D, Rocca F, Quattrone A, Avanzini G, Minassian B, Zara F. Clinical and genetic findings in 26 Italian patients with Lafora disease. Epilepsia. 2006;47:640\u20133.","journal-title":"Epilepsia"},{"issue":"4","key":"3976_CR12","doi-asserted-by":"publisher","first-page":"1202971","DOI":"10.3389\/fneur.2023.1202971","volume":"1","author":"G d'Orsi","year":"2023","unstructured":"d\u2019Orsi G, Farolfi A, Muccioli L, Palumbo O, Palumbo P, Modoni S, Allegri V, Garibotto V, Di Claudio MT, Di Muro E, Benvenuto M, Bisulli F, Carella M. Association of CSF and PET markers of neurodegeneration with electroclinical progression in Lafora disease. Front Neurol. 2023;1(4):1202971.","journal-title":"Front Neurol"},{"key":"3976_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2023.107012","volume":"199","author":"P Imbrici","year":"2024","unstructured":"Imbrici P, d\u2019Orsi G, Carella M, Nicolotti O, De Luca A, Altomare C, Liantonio A. Sodium-glucose cotransporter-2 inhibitors: A potential novel treatment for Lafora disease? Pharmacol Res. 2024;199: 107012.","journal-title":"Pharmacol Res"},{"issue":"Suppl 2","key":"3976_CR14","first-page":"S145","volume":"18","author":"R Michelucci","year":"2016","unstructured":"Michelucci R, Pasini E, Riguzzi P, Andermann E, K\u00e4lvi\u00e4inen R, Genton P. Myoclonus and seizures in progressive myoclonus epilepsies: pharmacology and therapeutic trials. Epileptic Disord. 2016;18(Suppl 2):S145\u201353.","journal-title":"Epileptic Disord"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03976-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-025-03976-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03976-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T04:30:59Z","timestamp":1757478659000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-025-03976-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,21]]},"references-count":14,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3976"],"URL":"https:\/\/doi.org\/10.1186\/s13023-025-03976-x","relation":{},"ISSN":["1750-1172"],"issn-type":[{"type":"electronic","value":"1750-1172"}],"subject":[],"published":{"date-parts":[[2025,8,21]]},"assertion":[{"value":"7 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"We declare that there are no conflicts of interest. We confirm that we have read the Journal\u2019s position on issues involved in ethical publication and affirm that this report is consistent with those guidelines.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}],"article-number":"447"}}